Cipla shares trade within inches of record high; check out latest triggers for drug maker

Cipla share price NSE, BSE: Cipla shares strengthened in a special session on Dalal Street on Saturday, March 2, coming within inches of a record high touched late last month, after the US Food and Drug Administration (FDA) completed inspections at a facility of the Mumbai-headquartered pharmaceutical company's Chinese subsidiary, Cipla Jiangsu, with zero observations. 

In a separate development, Kemwell Biopharma UK and MNI Ventures received confirmation from the US Secretary of State to form a joint venture with Cipla (EU), a subsidiary of the Indian drug maker. 

(This story will be updated shortly)

Catch the latest stock market updates here. For all other news related to business, politics, tech and auto, visit Zeebiz.com.